CSIR in the news..

An aggregation of news on the web about CSIR and its laboratories

Clinical trials of low-cost drug for infectious diseases

29 November 2012

HYDERABAD — The Council for Scientific and Industrial Research (CSIR), in a unique collaborative initiative to develop low-cost drugs for infectious diseases, is all set to taste its first success.

An anti-Tuberculosis molecule, developed through CSIR’s Open Source Drug Discovery (OSDD) initiative, will enter the first phase of clinical trials in a few months. This marks a major milestone for OSDD programme that links researchers across the globe to solve key challenges in designing drugs for tropical diseases like malaria and tuberculosis which fail to draw the attention of big pharmaceutical research companies……

Read more: http://www.khaleejtimes.com/displayarticle.asp?xfile=data/international/2012/November/international_November995.xml&section=international&col=

Advertisements

Written by csirindia

December 2, 2012 at 10:51 am

Posted in CSIR

%d bloggers like this: